Stock data
Zentalis Pharmaceuticals, Inc. (ZNTL)
Zentalis Pharmaceuticals, Inc. (ZNTL) reported revenue of US$0.00M and net income of -US$137.06M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$0.00M | — | -US$152.81M | -US$137.06M | — |
| 2024 | US$67.42M | — | -US$191.19M | -US$165.84M | — |
| 2023 | US$0.00M | — | -US$299.51M | -US$292.19M | — |
| 2022 | US$0.00M | — | -US$227.29M | -US$236.81M | — |
| 2021 | — | — | -US$216.54M | -US$158.72M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$42.29M | — |
| 2026-03-31 | — | -US$35.35M | — |
| 2025-12-31 | US$0.00M | -US$35.22M | — |
| 2025-09-30 | US$0.00M | -US$26.69M | — |
| 2025-06-30 | US$0.00M | -US$26.87M | — |
| 2025-03-31 | US$0.00M | -US$48.28M | — |
| 2024-12-31 | US$26.86M | -US$47.47M | — |
| 2024-09-30 | US$0.00M | -US$40.16M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.